Research Article

Open Access
The HDL particle composition determines its antitumor activity in pancreatic cancer
View ORCID ProfileRaimund Oberle Correspondence email, Kristina Kührer, Tamina Österreicher, View ORCID ProfileFlorian Weber, View ORCID ProfileStefanie Steinbauer, Florian Udonta, Mark Wroblewski, Isabel Ben-Batalla, Ingrid Hassl, View ORCID ProfileJakob Körbelin, Matthias Unseld, Matti Jauhiainen, Birgit Plochberger, View ORCID ProfileClemens Röhrl, Markus Hengstschläger, View ORCID ProfileSonja Loges, View ORCID ProfileHerbert Stangl
Raimund Oberle
1Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria
Roles: Conceptualization, Data curation, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Project administration, Writing—original draft, review, and editing
Kristina Kührer
1Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria
Roles: Data curation, Investigation, Methodology
Tamina Österreicher
1Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria
Roles: Data curation, Methodology
Florian Weber
2School of Medical Engineering and Applied Social Sciences, University of Applied Sciences Upper Austria, Linz, Austria
Roles: Data curation, Methodology
Stefanie Steinbauer
3Center of Excellence Food Technology and Nutrition, University of Applied Sciences Upper Austria, Wels, Austria
Roles: Data curation, Methodology
Florian Udonta
4Department of Oncology, Hematology and Bone Marrow Transplantation, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Roles: Data curation, Methodology
Mark Wroblewski
4Department of Oncology, Hematology and Bone Marrow Transplantation, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Roles: Conceptualization, Methodology
Isabel Ben-Batalla
5Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany
Roles: Data curation, Methodology
Ingrid Hassl
1Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria
Roles: Data curation, Methodology
Jakob Körbelin
6ENDomics Lab, Department of Oncology, Hematology and Bone Marrow Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Roles: Conceptualization, Methodology
Matthias Unseld
7Department of Medicine I, Division of Palliative Medicine, Medical University of Vienna, Vienna, Austria
Roles: Resources, Data curation
Matti Jauhiainen
8Minerva Foundation Institute for Medical Research and Finnish Institute for Health and Welfare, Genomics and Biobank Unit, Biomedicum 2U, Helsinki, Finland
Roles: Conceptualization, Methodology
Birgit Plochberger
2School of Medical Engineering and Applied Social Sciences, University of Applied Sciences Upper Austria, Linz, Austria
Roles: Resources, Methodology
Clemens Röhrl
3Center of Excellence Food Technology and Nutrition, University of Applied Sciences Upper Austria, Wels, Austria
Roles: Conceptualization, Resources, Methodology
Markus Hengstschläger
1Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria
Roles: Resources, Formal analysis
Sonja Loges
9Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
Roles: Conceptualization, Resources, Methodology
Herbert Stangl
1Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria
Roles: Conceptualization, Resources, Formal analysis, Methodology
Published 16 May 2022. DOI: 10.26508/lsa.202101317
HDL particle composition determines its antitumor activity
Raimund Oberle, Kristina Kührer, Tamina Österreicher, Florian Weber, Stefanie Steinbauer, Florian Udonta, Mark Wroblewski, Isabel Ben-Batalla, Ingrid Hassl, Jakob Körbelin, Matthias Unseld, Matti Jauhiainen, Birgit Plochberger, Clemens Röhrl, Markus Hengstschläger, Sonja Loges, Herbert Stangl
Life Science Alliance May 2022, 5 (9) e202101317; DOI: 10.26508/lsa.202101317
HDL particle composition determines its antitumor activity
Raimund Oberle, Kristina Kührer, Tamina Österreicher, Florian Weber, Stefanie Steinbauer, Florian Udonta, Mark Wroblewski, Isabel Ben-Batalla, Ingrid Hassl, Jakob Körbelin, Matthias Unseld, Matti Jauhiainen, Birgit Plochberger, Clemens Röhrl, Markus Hengstschläger, Sonja Loges, Herbert Stangl
Life Science Alliance May 2022, 5 (9) e202101317; DOI: 10.26508/lsa.202101317
In this Issue
Volume 5, No. 9
September 2022
Advertisement
Jump to section
Subjects
Related Articles
- No related articles found.
Cited By...
- No citing articles found.